165 related articles for article (PubMed ID: 14560310)
1. Characterisation of the dysferlin skeletal muscle promoter.
Foxton RM; Laval SH; Bushby KM
Eur J Hum Genet; 2004 Feb; 12(2):127-31. PubMed ID: 14560310
[TBL] [Abstract][Full Text] [Related]
2. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
[TBL] [Abstract][Full Text] [Related]
4. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.
Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R
Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147
[TBL] [Abstract][Full Text] [Related]
5. Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene.
Leshinsky-Silver E; Argov Z; Rozenboim L; Cohen S; Tzofi Z; Cohen Y; Wirguin Y; Dabby R; Lev D; Sadeh M
Neuromuscul Disord; 2007 Dec; 17(11-12):950-4. PubMed ID: 17825554
[TBL] [Abstract][Full Text] [Related]
6. Dysferlin and the plasma membrane repair in muscular dystrophy.
Bansal D; Campbell KP
Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
[TBL] [Abstract][Full Text] [Related]
7. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
[TBL] [Abstract][Full Text] [Related]
8. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
9. Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions.
Therrien C; Dodig D; Karpati G; Sinnreich M
J Neurol Sci; 2006 Dec; 250(1-2):71-8. PubMed ID: 16996541
[TBL] [Abstract][Full Text] [Related]
10. Novel DYSF mutations in Thai patients with distal myopathy.
Liewluck T; Pongpakdee S; Witoonpanich R; Sangruchi T; Pho-Iam T; Limwongse C; Thongnoppakhun W; Boonyapisit K; Sopassathit V; Phudhichareonrat S; Suthiponpaisan U; Raksadawan N; Goto K; Hayashi YK; Nishino I
Clin Neurol Neurosurg; 2009 Sep; 111(7):613-8. PubMed ID: 19493611
[TBL] [Abstract][Full Text] [Related]
11. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
12. Dysferlin and muscular dystrophy.
Bushby KM
Acta Neurol Belg; 2000 Sep; 100(3):142-5. PubMed ID: 11098285
[TBL] [Abstract][Full Text] [Related]
13. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
Piccolo F; Moore SA; Ford GC; Campbell KP
Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
[TBL] [Abstract][Full Text] [Related]
14. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).
Suzuki N; Aoki M; Hinuma Y; Takahashi T; Onodera Y; Ishigaki A; Kato M; Warita H; Tateyama M; Itoyama Y
Neurosci Res; 2005 May; 52(1):47-60. PubMed ID: 15811552
[TBL] [Abstract][Full Text] [Related]
16. Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1.
Yuan Z; Tie A; Tarnopolsky M; Bakovic M
Physiol Genomics; 2006 Jun; 26(1):76-90. PubMed ID: 16609143
[TBL] [Abstract][Full Text] [Related]
17. Developmental and tissue-specific regulation of a novel dysferlin isoform.
Salani S; Lucchiari S; Fortunato F; Crimi M; Corti S; Locatelli F; Bossolasco P; Bresolin N; Comi GP
Muscle Nerve; 2004 Sep; 30(3):366-74. PubMed ID: 15318348
[TBL] [Abstract][Full Text] [Related]
18. Proteomic investigation of the molecular pathophysiology of dysferlinopathy.
De Palma S; Morandi L; Mariani E; Begum S; Cerretelli P; Wait R; Gelfi C
Proteomics; 2006 Jan; 6(1):379-85. PubMed ID: 16302276
[TBL] [Abstract][Full Text] [Related]
19. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.
Lostal W; Bartoli M; Bourg N; Roudaut C; Bentaïb A; Miyake K; Guerchet N; Fougerousse F; McNeil P; Richard I
Hum Mol Genet; 2010 May; 19(10):1897-907. PubMed ID: 20154340
[TBL] [Abstract][Full Text] [Related]
20. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
